Colleagues from our BRC’s Mental Health in Development theme have established a network to facilitate relationships between schools and mental health researchers. The WISDOM Research Network brings together primary and…
The NIHR Mental Health Translational Research Collaboration (MH-TRC) secured over £42m of funding to establish the Mental Health Mission (MHM) in 2023. The MHM, in collaboration with the ASCEnD trial…
GPs will be able to support patients with difficult to treat depression through 7 new specialist clinics across the UK, widening access to clinical assessments and new treatments. The NIHR…
New research, supported by our BRC Molecular Targets’ Theme Co-Leads Professors Paul Harrison and Rachel Upthegrove and BRC Dementia Theme Co-Lead Professor Masud Husain, has found that patients who were…
Leading scientists say that while poor air quality is a risk factor for mental illness, progress in understanding the causes and impact has been too slow. In a paper published…
Triptans, a drug usually offered as an alternative to painkillers, have been found to be the most effective medicine for adults who experience acute migraines. Findings of a study, which…
Researchers from our BRC Data Science Theme have contributed to an article on the use of Electronic Health Records (EHRs) to facilitate personalised treatments for psychiatric conditions. Clinical prediction models…
This week, a product licence for the medicine lecanemab (Leqembi) was approved by the Medicines and Healthcare products Regulatory Agency (MHRA) to treat adult patients in the early stages of…
Research supported by University of Oxford’s Department of Experimental Psychology Prof. Anke Ehlers, Theme Lead of the BRC’s Psychological Treatments Theme, has found that the type of coping strategy used…
A prescription treatment for insomnia developed by Big Health has received US Food and Drug Administration (FDA) approval this week. Big Health joint co-founder University of Oxford’s Prof Colin Espie…
Increasing serotonin can change how people learn from negative information, as well as improving how they respond to it, according to a new study published in the leading journal Nature…
In a new paper published today in BJPsych it is suggested that a specific anti constipation drug, prucalopride may reduce the risk of experiencing depression in individuals with no past…
Many people who were hospitalised with COVID-19 continue to have cognitive and psychiatric problems even two to three years post-infection, according to a new study published today in Lancet Psychiatry….
Oxford University announces four new online therapies for anxiety and PTSD, now available on the NHS. The therapies target childhood anxiety and post-traumatic stress disorders and were developed with support form…
Researchers from the Biomedical Research Centre’s Preventing Multiple Morbidities Theme are looking into whether a ketogenic diet is an effective treatment for treatment-resistant depression (TRD). A ketogenic diet consists of…
A study into Alzheimer’s disease, completed by researchers in the BRC’s Dementia Theme, has found that data gathered from online cognition testing correlates to protein blood biomarker levels associated with…
The new recombinant shingles vaccine ‘Shingrix’ is associated with a reduced risk of dementia compared to an earlier shingles vaccine, according to a major new study published in Nature Medicine….
Researchers from the BRC’s Psychological Treatments Theme have contributed to a recent article on the programming characteristics of VR characters and their interpretations by people with paranoia. Paranoia, when a…
Semaglutide – widely known as Ozempic/Wegovy – does not negatively impact brain health and is associated with lower risk of cognitive problems and less nicotine dependence, according to a new…
In his article for Lady Margaret Hall News, University of Oxford’s Department of Psychiatry DPhil candidate Gulamabbas Lakha speaks about his experiences with faith and the study of theology and…
